HCPCS Level IIdrugActive
J9334
Inj efgart-alfa 2mg hya-qvfc
BETOS: O1D
Effective: 2024-01-01
Description
Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfc
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Vyvgart Hytrulo
Manufacturer
Argenx US, Inc
HCPCS Dosage
2 MG
Billing Units
500.0000
3
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.